Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

3.1K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustainability awareness among European dry eye disease specialists.

European journal of ophthalmology·2026
Same author

Long-term clinical outcomes in chronic ocular graft-versus-host disease: a retrospective cohort study.

Eye (London, England)·2026
Same author

Topical Losartan in Ophthalmology: Rationale, Experimental and Clinical Evidence, and Emerging Clinical Applications.

Journal of clinical medicine·2026
Same author

MPox virus transmission to healthcare worker in Europe.

Enfermedades infecciosas y microbiologia clinica (English ed.)·2026
Same author

Clinical Performance of an Enhanced Monofocal IOL Bilaterally Implanted in Patients Targeted for Monovision: A Prospective Study.

Journal of clinical medicine·2026
Same author

Management of persistent corneal epithelial defects: role of insulin.

Current opinion in ophthalmology·2026

Related Experiment Video

Updated: Dec 8, 2025

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

9.4K

Topical insulin for refractory persistent corneal epithelial defects.

David Diaz-Valle1, Barbara Burgos-Blasco1, Jose A Gegundez-Fernandez1

  • 1Opthalmology Department and Health Research Institute (IdISSC), Hospital Clinico San Carlos, Madrid, Spain.

European Journal of Ophthalmology
|September 21, 2020
PubMed
Summary

Insulin eye drops effectively promote corneal healing in persistent epithelial defects (PEDs) that resist standard treatments. This study found that topical insulin accelerated reepithelization, offering a well-tolerated and cost-effective therapeutic option.

Keywords:
Corneal epitheliumcorneal ulcerinsulinpersistent epithelial defect

More Related Videos

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
04:48

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Published on: November 22, 2024

623
Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

20.3K

Related Experiment Videos

Last Updated: Dec 8, 2025

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
11:13

Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells

Published on: April 7, 2016

9.4K
Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures
04:48

Establishing a Severe Corneal Inflammation Model in Rats Based on Corneal Epithelium Curettage Combined with Corneal Sutures

Published on: November 22, 2024

623
Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
07:29

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

20.3K

Area of Science:

  • Ophthalmology
  • Corneal Disease
  • Wound Healing

Background:

  • Persistent epithelial defects (PEDs) are a challenging clinical issue, often refractory to conventional therapies.
  • Understanding novel treatment strategies for PEDs is crucial for improving patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy of insulin eye drops in treating persistent epithelial defects (PEDs) refractory to standard care.
  • To analyze the impact of insulin eye drops on corneal epithelization.

Main Methods:

  • A prospective, non-randomized hospital-based study included 21 patients with refractory PEDs.
  • Patients received insulin eye drops four times daily, with outcomes measured by PED closure rate and healing time.

Main Results:

  • 81% of patients (17 out of 21) achieved reepithelization of their PEDs.
  • For those with successful closure, mean healing time was 34.8 days; remaining patients showed significant area reduction (91.5%).
  • Common PED etiologies included infectious keratitis, calcium keratopathy, and post-surgical defects.

Conclusions:

  • Topical insulin demonstrates potential in promoting and accelerating corneal reepithelization for refractory PEDs.
  • Insulin eye drops offer advantages such as good tolerance, accessibility, and cost-effectiveness.